Faron Pharmaceuticals Oy
FPHAF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $282,090 | $216,637 | $242,300 | $230,277 |
| - Cash | $9,503 | $29,979 | $6,875 | $6,315 |
| + Debt | $12,113 | $12,722 | $13,111 | $13,478 |
| Enterprise Value | $284,700 | $199,380 | $248,536 | $237,440 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$299 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$11 | -$16 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$14 | -$17 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.173 | -0.173 | -0.184 | -0.155 |
| % Growth | 199.8% | 5.9% | -18.7% | – |
| Operating Cash Flow | -$14 | -$9 | -$11 | -$12 |
| Capital Expenditures | $0 | $0 | $0 | -$117 |
| Free Cash Flow | -$14 | -$9 | -$11 | -$129 |